News
The first trial of an AI (Artificial Intelligence)-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine uptake and engagement with health professionals.
The first trial of an AI-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine ...
Marks’s ouster brings to a head a series of developments that seem to bolster concerns about the agency’s direction, including reportedly tasking a major player in the anti-vaccine community ...
This is the first patient to be dosed in Cohort 5 of the study, which involves a 70 mg once-daily dose of APR-1051 ... stress and DNA damage accumulation. HPV-driven cancers, including HPV+ ...
While HPV is a disease transmitted through sexual contact, the recommended ages for the two-dose HPV vaccine are 9 through ... dispatch.com or @samanthajhendr on X, formerly known as twitter.
“It felt like a playoff series,” reliever Chris Martin said. The Rangers (3-1) came out of that opening series with a winning record and carries those good vibes with them to ...
Researchers at the Dutch public health institute calculated that the chance of infection of two HPV variants among unvaccinated women dropped by 70 percent since the vaccination program was introduced ...
This study evaluated the effects of an extended dose interval on development of antibody and cell-mediated responses following the primary dose series and a subsequent ... The present study enrolled ...
stating that they “compare immune responses to HPV vaccination in CLWH [children living with HIV] by measuring antibody and memory B cell (Bmem) responses after 1, 2 or 3 doses of the 9-valent HPV ...
Britain has only enough vaccine to protect a third of the population from a terrorist smallpox attack, it emerged yesterday. Only 20 million doses of the lifesaving vaccine are stockpiled ...
Taking to X, the government ... for the HPV vaccine can have it. The NHS says you only cannot have the vaccine if you've had a serious allergic reaction (anaphylaxis) to a previous dose of the ...
The phase-3 clinical trials for both vaccines are aimed evaluating the efficacy and safety of the jabs in preventing the spread of TB among healthy household contacts of newly diagnosed TB patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results